Xiao Fang Pharma
60320722.240.91% ( +0.20 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Xiao Fang Pharma(603207) the Revenue is 145.69 M (+12.88%);the EBIT is 65.2 M (-4.17%);the EPS is 0.35 (-5.41%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.15B12.88%
----
----
EBIT
0.07B4.17%
----
----
EPS
0.355.41%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf